Nicorette Microtab 2mg sublingual tablets

Negara: Inggris

Bahasa: Inggris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Nicotine cyclodextrin complex

Tersedia dari:

McNeil Products Ltd

Kode ATC:

N07BA01

INN (Nama Internasional):

Nicotine cyclodextrin complex

Dosis:

2mg

Bentuk farmasi:

Sublingual tablet

Rute administrasi :

Sublingual

Kelas:

No Controlled Drug Status

Jenis Resep:

Valid as a prescribable product

Ringkasan produk:

BNF: 04100200; GTIN: 5010123726423 5010123726430 3574660474848

Selebaran informasi

651537
MICROTAB 2MG SUBLINGUAL TABLET
NICOTINE
WHAT YOU SHOULD KNOW ABOUT
NICORETTE
® 2MG SUBLINGUAL TABLET
Please read this leaflet carefully before
you start using this medicine. It provides
useful information on how to use it safely.
Keep the leaflet, you might need it again.
If you think you are having side-effects,
have any questions or are not sure about
anything please ask your doctor, nurse or
pharmacist.
1 WHAT THIS MEDICINE IS FOR
NICORETTE
®
Microtab is a nicotine
replacement therapy (NRT). It is used to
relieve withdrawal symptoms and reduce
the cravings for nicotine that you get when
you try to stop smoking, or when you are
cutting down the number of cigarettes you
smoke while trying to stop smoking.
To help cut down or quit smoking you
should also try to use a behavioural support
programme to increase your chances of
success.
IMPORTANT:
NICORETTE
®
Microtab is a
sublingual tablet which means it must
be dissolved under the tongue and NOT
swallowed or chewed.
WHAT DOES NICORETTE
® MICROTAB DO?
When you stop smoking, your body misses
the nicotine that you have been absorbing.
You may experience unpleasant feelings
and a strong desire to smoke (craving). This
indicates that you were dependent on
nicotine.
When you use NICORETTE
®
Microtab,
nicotine is released and passes into your
body through the lining of your mouth. The
nicotine released is sufficient to relieve the
unpleasant nicotine withdrawal symptoms.
It will also help to stop your craving to
smoke but will not give you the “buzz” you
get from smoking a cigarette.
The benefits of stopping smoking far
outweigh any potential risk from using
nicotine from NRT.
It is the toxins in cigarette smoke such as
tar, lead, cyanide and ammonia that cause
smoking related disease and death, not the
nicotine.
2 BEFORE USING THIS MEDICINE
X DO NOT USE NICORETTE
® MICROTAB:
n if you have an allergy to nicotine or any
of the other ingredients.
! TALK TO YOUR DOCTOR, NURSE OR
PHARMACIST...
n if you are pregnant or breast-feeding
– you may be able to use

Karakteristik produk

OBJECT 1
NICORETTE MICROTAB OR BOOTS NICASSIST 2 MG
MICROTAB
Summary of Product Characteristics Updated 29-Sep-2017 | McNeil
Products Ltd
1. Name of the medicinal product
Nicorette Microtab 2mg sublingual tablet or Boots NicAssist 2 mg
microtab.
2. Qualitative and quantitative composition
Nicotine ß-cyclodextrin complex 17.4 mg, equivalent to 2 mg nicotine.
For excipients see section 6.1
3. Pharmaceutical form
Sublingual tablet.
4. Clinical particulars
4.1 Therapeutic indications
This product is indicated for the relief of nicotine withdrawal
symptoms as an aid to smoking cessation in
adults and children over 12 years of age. It is also indicated in
pregnant and lactating women (see section
4.6).
In smokers currently unable or not ready to stop smoking abruptly,
this product may also be used as part
of a programme to reduce smoking prior to stopping completely.
If possible, this product should be used in conjunction with a
behavioural support programme.
4.2 Posology and method of administration
Behavioural therapy, advice and support will normally improve the
success rate.
SMOKING CESSATION
_Adults (over 18 years of age)_
The patient should make every effort to stop smoking completely during
treatment with this product .
The initial dose is based on the individual's nicotine dependence. The
tablet is used sublingually with a
recommended dose of one tablet per hour or, for heavy smokers (smoking
more than 20 cigarettes per
day), two tablets per hour. Allow the tablet to dissolve slowly (about
30 minutes).You should not swallow
or chew the tablet.
Increasing to two tablets per hour may be considered for patients who
fail to stop smoking with the one
tablet-per-hour regimen or for those whose nicotine withdrawal
symptoms remain so strong as to foresee
a relapse.
Most smokers require 8 to 12 or 16 to 24 tablets per day, not to
exceed 40 tablets. The duration of
treatment is individual, but up to three months of treatment is
recommended. The nicotine dose should
then be gradually reduced, by decreasing the total numb